a Faculdade de Ciências da Nutrição e Alimentação , Universidade do Porto , Porto , Portugal.
b Centro de Investigação Interdisciplinar Egas Moniz (CiiEM) , Instituto Universitário Egas Moniz , Almada , Portugal.
Ann Med. 2019;51(sup1):2-14. doi: 10.1080/07853890.2018.1564360.
Fibromyalgia (FM) is a chronic non-degenerative disease, whose nutritional therapy seems controversial. This systematic review aimed to synthesize the knowledge about the effect of dietary interventions on patient-reported outcomes (PRO) and inflammation in patients with FM. Six electronic databases - PubMed, BioMed Central, Cochrane library, EMBASE, LILACS and ISI - were searched for clinical trials, in which a dietary intervention in patients with FM diagnosed was conducted. Quality of evidence assessment was measured in accordance with GRADE methodology. Seven clinical trials - 3 randomized controlled trials, 1 unrandomized clinical trial and 3 uncontrolled clinical trials were identified. Dietary approaches included gluten-free diet ( = 1), raw vegetarian diet ( = 2), low Fermentable oligo-, di- and monossacharides, alcohols and polyols (FODMAPs) diet ( = 1), hypocaloric diet ( = 2) and monosodium glutamate- and aspartame-free diet interventions ( = 1). The major PRO were pain and functional repercussion, with 5 out of 7 studies reporting an improvement. The progress in secondary outcomes was reported for fatigue (2/5 studies), sleep quality (2/3 studies), depression and anxiety (3/6 studies), quality of life (4/5 studies), gastrointestinal symptoms (1/2 studies) and inflammatory biomarkers (1/1 study). However, according to Cochrane Risk of Bias, these studies had poor statistical quality. Well-designed studies should be performed to investigate the dietary interventions effect on FM. Key messages Fibromyalgia (FM) is a chronic non-degenerative disease, whose nutritional therapy seems controversial but promising. Pain and functional repercussion in FM patients seem to improve with a hypocaloric diet, a raw vegetarian diet or a low FODMAPs diet, as much as quality of life, quality of sleep, anxiety and depression and inflammatory biomarkers. Existing studies in this subject are scarce and low quality, which does not allow conclusions to be drawn.
纤维肌痛症(FM)是一种慢性非退行性疾病,其营养治疗似乎存在争议。本系统评价旨在综合有关饮食干预对纤维肌痛症患者报告结局(PRO)和炎症影响的知识。我们检索了六个电子数据库 - PubMed、BioMed Central、Cochrane 图书馆、EMBASE、LILACS 和 ISI - 以寻找对诊断为纤维肌痛症患者进行饮食干预的临床试验。证据质量评估按照 GRADE 方法进行。确定了 7 项临床试验 - 3 项随机对照试验、1 项非随机临床试验和 3 项非对照临床试验。饮食方法包括无麸质饮食( = 1)、生素食饮食( = 2)、低可发酵寡糖、二糖和单糖、多元醇(FODMAPs)饮食( = 1)、低热量饮食( = 2)和不含谷氨酸单钠和阿斯巴甜的饮食干预( = 1)。主要 PRO 为疼痛和功能影响,7 项研究中有 5 项报告有所改善。二级结局的进展情况报告了疲劳(5/5 项研究)、睡眠质量(3/3 项研究)、抑郁和焦虑(6/6 项研究)、生活质量(5/5 项研究)、胃肠道症状(2/2 项研究)和炎症生物标志物(1/1 项研究)。然而,根据 Cochrane 偏倚风险,这些研究的统计学质量较差。应开展设计良好的研究来调查饮食干预对纤维肌痛症的影响。关键信息纤维肌痛症(FM)是一种慢性非退行性疾病,其营养治疗似乎存在争议,但有一定前景。低热量饮食、生素食饮食或低 FODMAPs 饮食似乎可以改善纤维肌痛症患者的疼痛和功能影响,以及生活质量、睡眠质量、焦虑和抑郁以及炎症生物标志物。该主题的现有研究很少且质量较低,无法得出结论。